NextGen Concentrate on Recent Discovery That Most Tumours Are Derived From a Single Cancer-Initiating Cell Having Stem Cell Properties
Released on: November 9, 2007, 6:55 am
Press Release Author: Buzz121
Industry: Healthcare
Press Release Summary: NextGen have revealed that recent findings have concluded that cancer stem cells are not simply malignant counterparts of normal stem cells.
Press Release Body: NextGen are apparently focusing their business model on recent findings that cancer cells arise from progenitor cells that accumulate mutations in the genes that otherwise regulate normal cell growth and differentiation. According to groundbreaking research research, once the genes of cancerous have been altered, this becomes a crucial factor in tumour initiation.
NextGen are said to be concentrating on establishing a comprehensive approach that will enable a more targeted and accurate classification of malignant breast tumours for patient stratification. NextGen believes that this approach will ensure the development of tailor made personal treatment strategies aimed at effectively treating breast cancer.
Web Site: http://www.bakerwilcox.co.uk/nextgen/
Contact Details: NextGen Bioscience, Inc c/o MC Bio, 46 Aldgate High Street EC3N 1AL London, U.K. Attn. Graham May, Company Secretary
2012
